Trafalgar International (GCAN) EBT Margin (2017 - 2021)
Greater Cannabis Company (GCAN) posted quarterly EBT Margin of 308.5% for Q2 2021, down 260317.0% year-over-year from N/an in Q2 2020, and down 113.44% quarter-over-quarter from 2294.67% in Q2 2020.
Trafalgar International (GCAN) EBT Margin (2017 - 2021) Analysis & Trends
Greater Cannabis Company's EBT Margin history runs 5 years deep, the most recent figure standing at 308.5% for Q2 2021.
- In Q2 2021, EBT Margin fell 260317.0% year-over-year to 308.5%; the TTM figure through Dec 2021 stood at 4768.22% (down 295798.0% YoY), while the FY2021 annual figure was 4768.22%, down 278843.0% from the prior year.
- EBT Margin for Q2 2021 stood at 308.5%, down from 2294.67% in the prior quarter.
- The five-year high for EBT Margin was 2294.67% in Q2 2020, with the low at 45065.75% in Q2 2017.
- The 5-year median for EBT Margin is 308.5% (2021), against an average of 11147.95%.
- The sharpest annual moves came in 2018 and 2019: EBT Margin jumped 4516509 bps in 2018, then slumped 2438454 bps in 2019.
- Greater Cannabis Company's EBT Margin stood at 28305.15% in 2017, then surged by 100 bps to 28.16% in 2018, then tumbled by 86584 bps to 24356.38% in 2019, then soared by 109 bps to 2294.67% in 2020, then plunged by 113 bps to 308.5% in 2021.
- Business Quant data shows GCAN's EBT Margin at 308.5% in Q2 2021, 2294.67% in Q2 2020, and 24356.38% in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -308.50% |
| Jun 30, 2020 | 2,294.67% |
| Dec 31, 2019 | -24,356.38% |
| Sep 30, 2019 | -4,825.57% |
| Dec 31, 2018 | 28.16% |
| Jun 30, 2018 | 99.34% |
| Mar 31, 2018 | 107.62% |
| Sep 30, 2017 | -28,305.15% |
| Jun 30, 2017 | -45,065.75% |